摘要
结直肠癌(colorectal cancer,CRC)发病率高,致死性强,严重威胁人类健康。Septin9基因与CRC发生密切相关,其在癌组织中呈高度甲基化,是CRC的重要分子特征。检测Septin9基因在患者血浆中的甲基化水平对CRC筛查具有较为理想的效果。该法取样安全、方便,结果准确、稳定,有望取代传统的粪便潜血试验法与结肠镜检法。该文就近年来Septin9基因甲基化在CRC诊断中的研究进展作一综述。
引文
[1]Siegel RL,Miller KD,Fedewa SA,et al.Colorectal cancer statistics,2017[J].CA Cancer J Clin,2017,67(3):177-193.
[2]徐峰,王娟.结直肠癌患者血清SEPT9基因甲基化检测的研究进展[J].继续医学教育,2016,30(6):134-136.
[3]Wu D,Zhou G,Peng J,et al.Detection of colorectal cancer using a simplified SEPT9,gene methylation assay is a reliable method for opportunistic screening[J].J Mol Diagn,2016,18(4):535-545.
[4]Zhang M,He Y,Zhang X,et al.A pooled analysis of the diagnostic efficacy of plasmic methylated septin-9 as a novel biomarker for colorectal cancer[J].Biomed Rep,2017,7(4):353.
[5]Yuan P,Cheng X,Wu X,et al.OSMR and SEPT9:Promising biomarkers for detection of colorectal cancer based on blood-based tests[J].Tran Cancer Res,2016,5(2):131-139.
[6]Smith C,Dolat L,Angelis D,et al.Septin 9 exhibits polymorphic binding to F-actin and inhibits myosin and cofilin activity[J].J Mol Biol,2015,427(20):3273-84.
[7]Lyu N,Yao H,Xiao T,et al.Protein levels and its clinical significance of septin-9 and clusterin in peripheral blood of epithelial ovarian cancer patients[J].Zhonghua Fu Chan Ke Za Zhi,2015,50(9):679.
[8]Golan M,Mabjeesh NJ.Abstract 5112:In vivo molecular imaging of HIF-1 and septin 9 interaction by bimolecular fluorescence complementation[J].Cancer Res,2015,75(15):5112-5112.
[9]林春燕,税青林.SEPT9与恶性肿瘤的研究进展[J].泸州医学院学报,2013(2):186-188.
[10]Füchtbauer A,Lassen LB,Jense N AB,et al.Septin9 is involved in septin filament formation and cellular stability[J].Biol Chem,2016,392(8-9):769-777.
[11]Wasserkort R,Kalmar A,Valcz G,et al.Aberrant Septin9 DNA methylation in colorectal cancer is restricted to a single Cp G island[J].Bmc Cancer,2015,13(1):1-11.
[12]Zmarzly,Nikola,Wojdas,et al.DNA methylation:gene expression regulation[J].Folia Biologica Et Oecologica,2017,12(1):1-10.
[13]Golan M,Mabjeesh NJ.Imaging of hypoxia-inducible factor 1αand septin 9 interaction by bimolecular fluorescence complementation in live cancer cells[J].Oncotarget,2017,8(19):31830.
[14]陈纪飞,戴盛明.血浆甲基化Septin9基因:一个有潜力的结直肠癌早期筛查标志物[J].分子诊断与治疗杂志,2017,9(2):132-136.
[15]Tóth K,Sipos F,Kalmár A,et al.Detection of methylated SEPT9in plasma is a reliable screening method for both left-and right-sided colon cancers.[J].PLo S One,2012,7(9):46000.
[16]Warren JD,Xiong W,Bunker AM,et al.Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer[J].BMC Medicine,2014,9(1):133.
[17]Jin P,Kang Q,Wang X,et al.Performance of a second generation methylated SEPT9 test in detecting colorectal neoplasm[J].J Gastroenterol Hepatol,2015,305(5):830-833.
[18]郁迪,张小虎,鲁辛辛.血清SEPT9基因甲基化检测在结直肠癌诊断中的应用[J].临床检验杂志,2015,33(9):687-689.
[19]李士杰,刘艳刚,王警,等.外周血Septin9基因甲基化检测在结直肠癌筛查中的应用[J].中国普通外科杂志,2015,24(12):1756-1760.
[20]Church TR,Wandell M,Lofton-Day C,et al.Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer[J].Gut,2014,63(2):317-325.
[21]钟小琴.联合检测粪便Septin 9和Vimentin甲基化在结直肠癌临床筛查中的应用研究[D].广西:广西医科大学,2016.
[22]Lee HS,Hwang SM,Kim TS,et al.Circulating methylated Septin9nucleic Acid in the plasma of patients with gastrointestinal cancer inthe stomach and colon[J].Transl Oncol,2013,6(3):290-296.